Autopsy report · NCT01093846
38 Week Extension Study to CAIN457C2303
Cause of deathFutility
“Core Study in Behcet's disease with mostly active uveitis did not meet its primary endpoint”
Life of this trial
- Ran for about 10 months before it stopped.
- 59 participants enrolled.
- Results were posted on the registry 5 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Uveitis
- Interventions
- AIN457; AIN457; Placebo AIN457
- Participants
- 59
- Sites
- 25
- Countries
- Egypt, France, Germany, Greece, Hong Kong, Israel, Jordan, Singapore, South Korea, Spain, Taiwan, Tunisia and more
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.